Tarsus Pharmaceuticals, Inc. (TARS) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$24,595
Total Return
145.95%
CAGR
19.72%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.72% |
| Median | +1.02% |
| Best | +52.29% |
| Worst | -38.04% |
| % of Windows Positive | 51.9% |
1-Year (252 Trading Days)
| Average | +40.46% |
| Median | +36.52% |
| Best | +225.98% |
| Worst | -64.52% |
| % of Windows Positive | 68.4% |
3-Year (756 Trading Days)
| Average | +182.31% |
| Median | +177.36% |
| Best | +503.52% |
| Worst | -25.08% |
| % of Windows Positive | 93.0% |
Risk Metrics
| Maximum Drawdown | -71.29% |
| Average Drawdown | -33.76% |
| Drawdown Duration | 682 Trading Days |
| Sortino Ratio | 0.89 |
| Calmar Ratio | 0.28 |
| CVaR (5%) | -8.10% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -9.86% (-30.54% ann.) | $985.59 | $0.00 | $0.00 | $0.00 |
| 2025 | +47.88% | +$4787.79 | $0.00 | $0.00 | $0.00 |
| 2024 | +173.43% | +$17343.21 | $0.00 | $0.00 | $0.00 |
| 2023 | +38.13% | +$3813.10 | $0.00 | $0.00 | $0.00 |
| 2022 | -34.84% | $3484.44 | $0.00 | $0.00 | $0.00 |
| 2021 | -45.56% | $4556.02 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +100.83% (+2753.18% ann.) | +$10082.61 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | October 16, 2020 – November 6, 2020 | +22.45% | +3286.83% | +$2244.90 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +18.93% | +17.88% | +$1893.06 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -33.16% | -34.80% | $3315.79 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +72.21% | +34.08% | +$7221.30 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +126.76% | +68.52% | +$12675.88 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.